Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Reversibility of Diastolic Disfunction as a Prognostic Factor in Septic Shock

NCT03198611 is registered in ClinicalTrials.gov with Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau as lead sponsor.

NCT NCT03198611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Reversibility of Diastolic Disfunction as a Prognostic Factor in Septic Shock
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2018
Completion date
April 1, 2019
Enrollment
350 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic dysfunction, septic shock